Alex Zhavoronkov, PhD Presents at Jefferies (IMAGE)
Caption
Zhavoronkov will share updates on Insilico’s rapidly progressing pipeline of novel therapeutics available for partnering and licensing, and showcase its new AI-driven fully robotic target discovery and validation platform, and end-to-end drug discovery platform, Pharma.AI.
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content